Cancer Cells May Offer Protection Against Alzheimer's: A Molecular Mystery Unraveled in Mice
For decades, a curious observation has lingered in the medical community: cancer and Alzheimer’s disease are rarely found together in the same individual. This seemingly paradoxical relationship has fueled speculation that a history of cancer might somehow offer a degree of protection against the debilitating neurodegenerative condition. Now, a groundbreaking study conducted on mice provides a potential molecular explanation for this medical mystery, revealing that a proteiin produced by cancer cells appears to infiltrate the brain, where it helps to break down clumps of misfolded proteiins commonly associated with Alzheimer’s disease. The study, the result of 15 years of dedicated research, was published on January 22nd in the prestigious journal Cell and holds promise for guiding the development of new drugs to treat Alzheimer’s disease.
“They have a piece of the puzzle,” explains Donald Weaver, a neurologist and chemist at the Krembil Research Institute at the University of Toronto in Canada, who was not involved in the study. “It’s not the full picture by any stretch of the imagination, but it’s an interesting piece.” Weaver has been fascinated by this connection since early in his medical training, recalling a senior pathologist’s remark: “If you see someone with Alzheimer’s disease, they’ve never had cancer.” This observation resonated with Weaver throughout his career, as he diagnosed thousands of patients with Alzheimer’s disease, rarely encountering anyone with a prior cancer diagnosis.
While epidemiological data don’t present such a clear-cut division, a 2020 meta-analysis of data from over 9.6 million people revealed an 11% decreased incidence of Alzheimer’s disease among those who had been diagnosed with cancer. However, establishing a definitive link has been challenging, as researchers must account for various confounding factors. For instance, individuals might die of cancer before they reach the age where Alzheimer’s disease symptoms typically manifest, and some cancer treatments can induce cognitive difficulties, potentially obscuring an Alzheimer’s diagnosis.
Despite these complexities, the accumulated data have been compelling enough to motivate Youming Lu, a neurologist at Huazhong University of Science and Technology in Wuhan, China, to investigate the underlying biological mechanisms driving this observed trend. Lu’s laboratory embarked on a six-year research endeavor to model the interplay between cancer and Alzheimer’s disease in mice. The team strategically transplanted three different types of human tumors – lung, prostate, and colon – into mouse models susceptible to developing Alzheimer’s-like symptoms. Remarkably, the mice with cancer did not develop the characteristic brain plaques associated with Alzheimer’s disease. This observation prompted the researchers to investigate the “why” behind this protective effect.
The researchers meticulously screened the proteiins secreted by these cancer cells, searching for those capable of crossing the blood-brain barrier – the protective shield that normally prevents substances from entering the brain – and infiltrating the brain tissue. This extensive search, spanning over six years, narrowed the focus to a single proteiin: cystatin C. Cystatin C is known to regulate the activity of proteases, enzymes that break down proteiins. In the context of Alzheimer’s disease, this suggests that cystatin C may be helping to break down the harmful amyloid plaques that accumulate in the brains of Alzheimer’s patients.
The findings of this study offer a tantalizing glimpse into a potential therapeutic avenue for Alzheimer’s disease. By understanding the molecular mechanisms underlying the protective effect of cancer, researchers may be able to develop drugs that mimic the action of cystatin C, thereby preventing or slowing the progression of Alzheimer’s disease. While much work remains to be done, this research represents a significant step forward in our understanding of this devastating condition and offers renewed hope for the development of effective treatments. The discovery highlights the complex and often unexpected ways in which different diseases can interact, and underscores the importance of continued research to unravel the mysteries of the human body.
Source:
